Administration of an inhibitory peptide blocking p113-ZRF1 interaction suppresses FAO, mitochondrial complex I activity, tumorigenesis, and aggressiveness of NB cells, indicating the oncogenic roles of p113 and ZRF1 in lipid metabolic reprogramming and NB progression. This evidence concerns the gene STAT2 and neuroblastoma.